A “body armor” of leukemia cutis

descriptionPublicationkeyboard_double_arrow_right Article 25 Feb 2015 Netherlands English Publisher:WileyJournal:American Journal of Hematology, volume 90, pages 751-751 (issn: 0361-8609, eissn: 1096-8652,

Copyright policy )

Authors: Janssen, N.A.; Hebeda, K.M.; Stevens, W.B.C.; Velden, W.J.F.M. van der;

doi: 10.1002/ajh.23948

pmid: 25611338

handle: 2066/152394

A “body armor” of leukemia cutis

- Summary
- Subjects
- Metrics

Abstract

Item does not contain fulltext

Country

Netherlands

Related Organizations

Radboud University Nijmegen Medical Centre
Netherlands
Radboud University Nijmegen
Netherlands

Keywords

Adult, Skin Neoplasms, Daunorubicin, Remission Induction, Hematopoietic Stem Cell Transplantation, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Antineoplastic Agents, Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences, Leukemia, Myeloid, Acute, Fatal Outcome, Cell Movement, Recurrence, Humans, Transplantation, Homologous, Female, Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences, Sarcoma, Myeloid, Idarubicin, Skin

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average